• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型波士顿人工角膜移植术后无光感结局

No Light Perception Outcomes Following Boston Keratoprosthesis Type 1 Surgery.

作者信息

Muzychuk Adam K, Durr Georges M, Shine Julien J, Robert Marie-Claude, Harissi-Dagher Mona

机构信息

Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montreal, Quebec, Canada.

Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montreal, Quebec, Canada.

出版信息

Am J Ophthalmol. 2017 Sep;181:46-54. doi: 10.1016/j.ajo.2017.06.012. Epub 2017 Jun 27.

DOI:10.1016/j.ajo.2017.06.012
PMID:28662941
Abstract

PURPOSE

To determine the incidence rate, principal causes, and clinical course of eyes developing no light perception (NLP) visual acuity (VA) following Boston Keratoprosthesis (B-KPro) type 1 surgery. Secondary objectives include determining the incidence rate, relative risk (RR), and survival probability with respect to NLP outcomes among eyes with congenital aniridia.

DESIGN

Retrospective, interventional case series.

SUBJECTS

All patients undergoing B-KPro type 1 surgery between October 2008 and June 2016 by a single surgeon at CHUM - Hôpital Notre-Dame.

METHODS

Records of patients having undergone B-KPro implantation were reviewed. Eyes with a final outcome of NLP were further reviewed to determine best recorded postoperative VA, time to NLP onset, clinical course, and principal cause. Descriptive statistics, incidence rates, Kaplan-Meier survival curves, and the RR of NLP outcomes among eyes with aniridia were determined. Statistical significance was defined as P < .05.

RESULTS

Records of 119 patients were included, with an average follow-up of 49.1 ± 26.8 months postoperatively. Nineteen eyes had a final outcome of NLP, representing 16.0%. The incidence rate of NLP was 0.04 cases per eye-year of follow-up. The most common principal causes were inoperable retinal detachment (n = 7, 36.8%), terminal glaucoma (n = 6, 31.6%), and carrier graft melt-related complications (n = 5, 26.3%). The RR of developing NLP among eyes with aniridia was 3.04 (P = .01).

CONCLUSIONS

No light perception is a devastating but uncommon outcome of B-KPro surgery. Patients with aniridia seem to be at increased risk. In spite of all available medical and surgical interventions, some eyes may still suffer this outcome.

摘要

目的

确定接受1型波士顿人工角膜(B-KPro)手术后出现无光感(NLP)视力(VA)的眼睛的发病率、主要病因及临床病程。次要目标包括确定先天性无虹膜患者眼睛出现NLP结局的发病率、相对风险(RR)及生存概率。

设计

回顾性干预性病例系列研究。

研究对象

2008年10月至2016年6月期间在蒙特利尔大学中心医院圣母医院由同一位外科医生进行1型B-KPro手术的所有患者。

方法

回顾接受B-KPro植入手术患者的记录。对最终结局为NLP的眼睛进行进一步评估,以确定术后最佳记录视力、NLP发生时间、临床病程及主要病因。确定描述性统计数据、发病率、Kaplan-Meier生存曲线以及无虹膜患者眼睛出现NLP结局的RR。统计学显著性定义为P < 0.05。

结果

纳入119例患者的记录,术后平均随访时间为49.1 ± 26.8个月。19只眼睛最终结局为NLP,占16.0%。NLP的发病率为每眼随访年0.04例。最常见的主要病因是无法手术的视网膜脱离(n = 7,36.8%)、终末期青光眼(n = 6,31.6%)以及供体植片融化相关并发症(n = 5,26.3%)。无虹膜患者眼睛出现NLP的RR为3.04(P = 0.01)。

结论

无光感是B-KPro手术的一种严重但不常见的结局。无虹膜患者似乎风险更高。尽管采取了所有可用的药物和手术干预措施,一些眼睛仍可能出现这种结局。

相似文献

1
No Light Perception Outcomes Following Boston Keratoprosthesis Type 1 Surgery.1型波士顿人工角膜移植术后无光感结局
Am J Ophthalmol. 2017 Sep;181:46-54. doi: 10.1016/j.ajo.2017.06.012. Epub 2017 Jun 27.
2
Glaucoma associated with Boston type I keratoprosthesis.与 Boston Ⅰ型角膜移植术相关的青光眼。
Cornea. 2012 Feb;31(2):134-9. doi: 10.1097/ICO.0b013e31820f7a32.
3
Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.无虹膜症合并波士顿 1 型角膜假体患者的青光眼管理。
Am J Ophthalmol. 2019 Nov;207:258-267. doi: 10.1016/j.ajo.2019.06.018. Epub 2019 Jun 24.
4
Boston type 1 keratoprosthesis: the CHUM experience.波士顿 1 型角膜假体:CHUM 经验。
Can J Ophthalmol. 2011 Apr;46(2):164-8. doi: 10.3129/i10-103.
5
Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.Boston 角膜移植术 1 型手术后青光眼的危险因素和结果。
Am J Ophthalmol. 2021 Jun;226:56-67. doi: 10.1016/j.ajo.2021.01.006. Epub 2021 Jan 22.
6
Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.波士顿1型人工角膜治疗无虹膜症的中期和长期疗效
Cornea. 2018 Jan;37(1):11-14. doi: 10.1097/ICO.0000000000001412.
7
Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.蒙特利尔大学无虹膜患者植入波士顿1型人工角膜后的结果
Am J Ophthalmol. 2014 Aug;158(2):270-276.e1. doi: 10.1016/j.ajo.2014.05.009. Epub 2014 May 17.
8
Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.1型波士顿人工角膜:加拿大两个中心的治疗结果
Can J Ophthalmol. 2016 Apr;51(2):76-82. doi: 10.1016/j.jcjo.2015.12.015.
9
Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.I 型波士顿角膜成形术治疗先天性无虹膜症的虹膜纤维变性综合征的手术和视觉效果。
Am J Ophthalmol. 2012 May;153(5):967-971.e2. doi: 10.1016/j.ajo.2011.10.027. Epub 2012 Jan 21.
10
The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.波士顿 II 型角膜假体:马萨诸塞州眼耳医院的经验。
Cornea. 2011 Dec;30(12):1298-303. doi: 10.1097/ICO.0b013e318215207c.

引用本文的文献

1
The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.终末期角膜疾病的治疗:穿透性角膜移植术与波士顿 1 型角膜假体的比较。
Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2781-2790. doi: 10.1007/s00417-022-05646-1. Epub 2022 Apr 6.
2
Commentary: Long-Term Anatomical and Functional Survival of Boston Type 1 Keratoprosthesis in Congenital Aniridia.评论:波士顿1型人工角膜在先天性无虹膜患者中的长期解剖学和功能存活情况
Front Med (Lausanne). 2021 Dec 23;8:815926. doi: 10.3389/fmed.2021.815926. eCollection 2021.